结核分枝杆菌分泌蛋白Rv2647通过泛素化调控抑制巨噬细胞焦亡的机制研究
批准号:
82070017
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
冯旰珠
依托单位:
学科分类:
呼吸系统感染、炎症与免疫
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
冯旰珠
中文摘要
结核分枝杆菌(Mtb)在巨噬细胞(Mφ)中存活是结核病复发与传播的主要原因,Mφ焦亡是清除其存活的重要途径。Rv2647是Mtb的分泌蛋白,有关其影响Mφ焦亡的相关研究未见文献报道。我们前期研究发现:Rv2647刺激Mφ后,Mφ焦亡明显受抑,且Mφ对Mtb清除能力、NLRP3表达及Caspase-1活化皆显著下降,E3泛素连接酶ARIH2及TRIM31表达及NLRP3的K48位多聚泛素化修饰明显增强;此外,刺激后,miR-20/142表达显著下降,Akt磷酸化水平显著上升,PI3K抑制剂可逆转miR及Akt变化。据此,我们拟通过体内外研究证实如下机制:Mtb感染Mφ,Rv2647通过激活PI3K/Akt信号通路,下调miR-20/142表达,促进ARIH2及TRIM31表达,后两者靶向修饰NLRP3促进K48位多聚泛素化与降解,使Caspase-1活化受阻,从而抑制Mφ焦亡利于Mtb存活。
英文摘要
Tuberculosis is an important infectious disease that threatens human health.The main reason of the recurrence and spread of the disease is that M.tb could be survival in macrophages(Mφ),and the Mφ pyroptosis is an important way to eliminate it. Rv2647 is a secreted protein of M.tb, and no data have been focused on its influence on the host Mφ pyroptosis so far.Our preliminary results showed that the clearing ability of Mφ to M.tb was significantly reduced, the expression levels of pyroptosis marker p30-GSDMD and inflammasome NLRP3 was markedly decreased, the activation level of caspase-1was obviously declined, and the expression of E3 ubiquitin ligases ARIH2 and TRIM31 and K48 of NLRP3 polyubiquitination modifications were significantly enhanced after Rv2647 stimulated Mφ. In addition, miR-20 and miR-142 expression was decreased significantly, Akt phosphorylation was increased distinctly, while the PI3K inhibitors could reverse the changes of miRNA and Akt. As has been mentioned, we intend to confirm the following mechanism through in vivo and in vitro: M.tb secreted protein Rv2647 can down-regulates the expression of miR-20 and miR-142 by activating the PI3K/Akt signaling pathway, and promotes the expression of ARIH2 and TRIM31,which target modification of NLRP3 to promotes the K48 polyubiquitination and degradation, follow up blocking caspase-1 activation, thus inhibiting macrophage pyroptosis and benefit to M.tb survival.
炎性小体介导的细胞焦亡和炎性细胞因子释放在宿主防御病原体中发挥重要作用,结核分枝杆菌(M. tb)是一种典型的胞内病原体,其如何逃避免疫清除并持续存活于巨噬细胞(Mφ)在很大程度上尚不清楚。本研究深入探讨了Rv2647蛋白作为M. tb的关键毒力因子,通过抑制宿主Mφ焦亡削弱其对M. tb清除能力的潜在机制。本研究结果表明:Rv2647蛋白是M. tb一种关键毒力因子,可显著抑制Mφ焦亡并削弱其对M. tb的清除;Rv2647通过增强NLRP3泛素化并促进其降解,导致NLRP3/caspase-1/GSDMD失活及IL-1β分泌减少,抑制宿主对M. tb的清除并加重肺组织损伤;此外,Rv2647可能通过与ISG15结合,竞争性地抑制NLRP3的ISG修饰,增强NLRP3泛素化并促进其降解。在本研究中,Rv2647首次被确定为M. tb的关键毒力因子,其作用于Mφ后与ISG15结合,竞争性地抑制NLRP3的ISG修饰并增强其泛素化降解,进而抑制Mφ焦亡及对M. tb的清除,为M. tb感染防治提供潜在的药物筛选靶点及疫苗抗原。
铜绿假单胞菌分泌蛋白PA3125通过诱导肺泡巨噬细胞PKM2甲基化修饰抑制抗原提呈的机制研究
-
批准号:82370014
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:冯旰珠
-
依托单位:
铜绿假单胞菌分泌蛋白Pec1抑制巨噬细胞自噬影响细菌清除的机制研究
-
批准号:81870009
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:冯旰珠
-
依托单位:
铜绿假单胞菌PA3611蛋白诱导支气管上皮细胞-间充质细胞转化的机制研究
-
批准号:81670013
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:冯旰珠
-
依托单位:
结核分枝杆菌Rv2346c蛋白对巨噬细胞免疫抑制效应的机制研究
-
批准号:81470209
-
项目类别:面上项目
-
资助金额:75.0万元
-
批准年份:2014
-
负责人:冯旰珠
-
依托单位:
国内基金
海外基金